I participated and presented my work in "MicroRNAs Europe 2012" Meeting on 'MicroRNAs: Biology to Development & Disease' which was held at Peterhouse College of the University of Cambridge, Cambridge, United Kingdom on November 1 - 2, 2012. It was organised by GeneExpression Systems, Inc. Waltham, USA. I found it much focused meeting, and the organising committee had selected very few internationally reputed scientists from academia, biotech and pharmaceutical industry that work in the applications of RNAs towards the development of new drugs and diagnostics in order to treat diseases. It was a great opportunity for me to interact with the scientists from RNA Biology area and had discussion about there ongoing developments mainly focussing on RNA therapeutics which may also help me to improvise my current project with novel ideas and technique which I came across during the meeting. I was auspicious to present a poster titled "Selection and characterization of Regnase-1 RNA-binding aptamers to decode the regulatory mechanism played by Regnase-1". I found this meeting was magnificent opportunity for me to present and share my research with proficient scientists and professionals from the field of RNA. The primary aim of the meeting was to connect the academia and industry experts for the benefit of developing scientific and business collaborations. The conference was well organized and categorized into two days programme. The meeting was divided into eight sessions. New methods for detection, imaging and manipulation of nano-objects: going beyond fluorescence labeling and optical tweezing was presented, which I felt was very valuable. Besides many important talks, one short talk given by Nunilo Cremades, on Single Molecule Fluorescence & Imaging studies to characterize the surface of live cells was very interesting and significant area which I came across during the meeting.

It would be a great pleasure if I get such chance again in near future which can help me to link and connect RNA biology area with immunology as I am working on RNA aptamers and RNA therapeutic against molecules which have relevance in immunology. Attending this kind of greatly interactive meeting in near future will surely improvise the quality of science.

After meeting I had some great time in travelling and visiting Cambridge University and famous places of London.

I would like to thanks IFreC and the organizers and committee members for giving me a chance to attend this valuable meeting.


Jyoti Bala